| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/29/2014 | CN102816816B Bacillus sphaericus parasporal crystal protein preparation method and application thereof |
| 01/29/2014 | CN102796171B Double saturated aliphatic chain alcohol His-Gly-Glu-Asp tetrapeptide esters and preparation method and application thereof |
| 01/29/2014 | CN102796170B Double saturated aliphatic chain alcohol His-Gly-Lys-Asp tetrapeptide esters and preparation method and application thereof |
| 01/29/2014 | CN102796169B Double saturated aliphatic chain alcohol Glu-Asp-Gly-Asp tetrapeptide esters and preparation method and application thereof |
| 01/29/2014 | CN102657847B Application of toad maggot protein in medicine used for treating rectal cancer |
| 01/29/2014 | CN102617707B Preparation method of new homologue 2-methyl-actinomycin D of actinomycin D |
| 01/29/2014 | CN102397527B Medicinal composition and application thereof |
| 01/29/2014 | CN102341112B Method and means for producing tissues and tissues obtained |
| 01/29/2014 | CN102294014B Hepatocyte growth-promoting factor and preparation and application thereof |
| 01/29/2014 | CN102294013B Hepatocyte growth-promoting factor and application thereof |
| 01/29/2014 | CN102234316B Polypeptides capable of enhancement of acid sensing ion channels 1a current, and use thereof |
| 01/29/2014 | CN101939443B Modified leptin polypeptides and their uses |
| 01/29/2014 | CN101912600B Method for improving stability of insulin in solution |
| 01/29/2014 | CN101842109B Peptides derivatized with A-B-C-D- and their therapeutical use |
| 01/29/2014 | CN101698681B Chimeric polypeptide with dual-targeting function and applications thereof |
| 01/29/2014 | CN101448850B Immunomodulating oligopeptides |
| 01/29/2014 | CN101400406B Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 01/29/2014 | CN101022821B Use of aspartate for regulating glucose levels in blood |
| 01/28/2014 | US8637658 Non-fluorescent quencher compounds and biomolecular assays |
| 01/28/2014 | US8637647 Method of acylating a peptide or protein |
| 01/28/2014 | US8637646 Growth hormone variants |
| 01/28/2014 | US8637638 Method and composition for altering a B cell mediated pathology |
| 01/28/2014 | US8637635 Peptides that selectively home to heart vasculature and related conjugates and methods |
| 01/28/2014 | US8637578 Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins |
| 01/28/2014 | US8637571 Compositions and methods for the intraocular transport of therapeutic agents |
| 01/28/2014 | US8637479 Compounds and methods for the treatment of inflammatory diseases of the CNS |
| 01/28/2014 | US8637472 Optimized dengue virus entry inhibitory peptide (10AN) |
| 01/28/2014 | US8637471 Fertilization prediction and promotion |
| 01/28/2014 | US8637470 Small humanin-like peptides |
| 01/28/2014 | US8637469 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| 01/28/2014 | US8637468 Synthetic cholesterylamine-linker derivatives for agent delivery into cells |
| 01/28/2014 | US8637467 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof |
| 01/28/2014 | US8637465 Fibroblast growth factor receptor-derived peptides binding to NCAM |
| 01/28/2014 | US8637464 P75NTR screening assay |
| 01/28/2014 | US8637463 Peptide inhibiting angiotensin converting enzyme |
| 01/28/2014 | US8637462 Methods for reducing platelet counts and/or platelet adhesion by administering a GC-B receptor agonist |
| 01/28/2014 | US8637461 Method of diagnosing and treating oxidative stress-impaired wound healing |
| 01/28/2014 | US8637460 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
| 01/28/2014 | US8637459 Enhancing a population of insulin releasing cells using GFR-A1 agonists |
| 01/28/2014 | US8637458 Insulin with a stable basal release profile |
| 01/28/2014 | US8637457 Processes and intermediates |
| 01/28/2014 | US8637456 Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
| 01/28/2014 | US8637455 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 01/28/2014 | US8637454 Treatment of mucositis with kallikrein inhibitors |
| 01/28/2014 | US8637452 Water soluble membrane proteins and methods for the preparation and use thereof |
| 01/28/2014 | US8637451 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/28/2014 | US8637450 Methods of promoting fat loss comprising administering an ALK7 inhibitor |
| 01/28/2014 | US8637449 Processes for preparing protease inhibitors of hepatitis C virus |
| 01/28/2014 | US8637448 Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface |
| 01/28/2014 | US8637306 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids |
| 01/28/2014 | US8637305 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 01/28/2014 | US8637262 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof |
| 01/28/2014 | US8637077 Sustained-release preparation |
| 01/28/2014 | US8637075 Colostrum composition |
| 01/28/2014 | US8637043 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 01/28/2014 | US8637034 Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein |
| 01/28/2014 | US8637031 Method of treating osteoarthritis with an antibody to NGF |
| 01/28/2014 | US8637029 Methods for the treatment of gout |
| 01/28/2014 | US8637024 Fusion antibodies for HIV therapy |
| 01/28/2014 | US8637023 Hemojuvelin fusion proteins |
| 01/28/2014 | US8637022 Functionalized polypeptides |
| 01/28/2014 | US8637020 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
| 01/28/2014 | US8637013 Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis |
| 01/28/2014 | US8637010 Method of accelerating wound healing by administration of plasminogen |
| 01/28/2014 | US8637009 Thermostabilization of proteins |
| 01/28/2014 | US8637008 Polymers for reversing heparin-based anticoagulation |
| 01/28/2014 | US8637007 Factor VIIa-polysialic acid conjugate having prolonged in vivo half-life |
| 01/28/2014 | US8636997 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist |
| 01/28/2014 | US8636995 Methods and devices to regulate stem cell homing |
| 01/28/2014 | US8636977 Integrin targeted synthetic ligands for diagnostic and therapeutic applications |
| 01/28/2014 | CA2720141C Beta-turn peptidomimetic cyclic compounds for treating dry eye |
| 01/28/2014 | CA2634647C Metastin derivatives and use thereof |
| 01/28/2014 | CA2616877C Systems and methods for manufacturing liposomes |
| 01/28/2014 | CA2584805C Peptide anti-tumor agent |
| 01/28/2014 | CA2533124C Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
| 01/28/2014 | CA2502690C Compstatin analogs with improved activity |
| 01/28/2014 | CA2492295C Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 01/28/2014 | CA2456593C Peptides for the diagnosis, monitoring and treatment of diabetes |
| 01/28/2014 | CA2431916C New therapeutic uses of smr1 peptides |
| 01/28/2014 | CA2399063C A method for maintaining or improving the synthesis of mucins |
| 01/28/2014 | CA2307017C Erythropoietin-mediated neurogenesis |
| 01/23/2014 | WO2014015338A1 Acetylated crystallin polypeptides and mimetics thereof as therapeutics agents |
| 01/23/2014 | WO2014015314A1 Recombinant c7 and methods of use |
| 01/23/2014 | WO2014015175A1 Compositions and methods for modulating brd4 bioactivity |
| 01/23/2014 | WO2014015148A1 Human btnl3 proteins, nucleic acids, and antibodies and uses thereof |
| 01/23/2014 | WO2014015133A1 Treatment of osteoarthritis using il-20 antagonists |
| 01/23/2014 | WO2014015078A1 O-linked carbohydrate-modified insulin analogues |
| 01/23/2014 | WO2014014938A1 Alpha-galactosidase a and 1-deoxygalactonojirimycin co-formulation |
| 01/23/2014 | WO2014014899A1 Compositions and methods for detecting, treating and preventing diseases and disorders |
| 01/23/2014 | WO2014014819A2 Methods of treating glucose metabolism disorders |
| 01/23/2014 | WO2014014816A2 Methods of treating glucose metabolism disorders |
| 01/23/2014 | WO2014014530A1 Ursolic acid salts for treating diabetes and obesity |
| 01/23/2014 | WO2014014410A1 Angiopoietin-like 4 and a method of its use in wound healing |
| 01/23/2014 | WO2014014384A1 Drug having an antiviral, anti-inflammatory, immuno-modulating and analgesic effect |
| 01/23/2014 | WO2014014154A1 Antioxidant stabilising composition comprising alloferon |
| 01/23/2014 | WO2014013413A1 Hydrosoluble film having healing activity |
| 01/23/2014 | WO2014013060A1 Osteopontin peptide fragments for use in suppression or prevention of tumor growth |
| 01/23/2014 | WO2014013036A1 Inhibitors of the cd95 signaling pathway for treatment of mds |
| 01/23/2014 | WO2014013032A1 Hip/pap protein and derivatives thereof for use in treating cancer |
| 01/23/2014 | WO2014013029A1 Use of preparations comprising exosomes derived from mesenchymal stem cells (mscs) in the prevention and therapy of inflammatory conditions |